Home/Sareum/Stephen Parker

SP

Stephen Parker

Executive Chairman

Therapeutic Areas

Autoimmune Diseases Oncology

Sareum Pipeline

Drug	Indication	Phase
SDC-1801	Autoimmune Diseases	Phase 1/2
SDC-1802	Autoimmune Diseases	Preclinical
CHK1 Inhibitor Program	Oncology	Preclinical